AstraZeneca’s COVID-19 vaccine and clotting risks

Dr. Jen Ashton interprets the latest headlines surrounding the vaccine.
1:20 | 04/08/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:



Skip to this video now

Now Playing:


Related Extras
Related Videos
Video Transcript
Transcript for AstraZeneca’s COVID-19 vaccine and clotting risks
Friday being my most favorite. And we have ABC's chief medical correspondent Dr. Jen Ashton here and let's take a look at the latest numbers from Johns Hopkins university university. More than 133.1 million cases of coronavirus confirmed worldwide, the death toll here in the U.S. Now closing in on that 560,000 mark, as the CDC reports more than 109.4 million adults have received at least one dose of the vaccine. That's 42% of adults here in the U.S., Dr. Ashton, three million people a day are being vaccinated, we have three FDA-approved vaccines out there, but, astrazeneca, we keep hearing issues with astrazeneca. This is a big headline today, guys, so let's go through what we need to know about this, on the European union and the U.K., separately investigated the story, we talked about it here, of possible rare clotting events associated with this vaccine. What they found initially is a plausible link that they had said requires further investigation. Important to put in this into numerical context. The risk at this time, very, very rare. One in 250,000, and they are still underscoring that at this time, overall, the benefits of this vaccine outweigh these rare risks, but they are looking into it. Dr. Ashton, appreciate you as

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"1:20","description":"Dr. Jen Ashton interprets the latest headlines surrounding the vaccine.","mediaType":"default","section":"ABCNews/GMA","id":"76948838","title":"AstraZeneca’s COVID-19 vaccine and clotting risks","url":"/GMA/GMA3/video/astrazenecas-covid-19-vaccine-clotting-risks-76948838"}